Core Viewpoint - The stock of Te Yi Pharmaceutical experienced a decline of 2.15% on December 23, with a current price of 10.93 CNY per share and a market capitalization of 5.607 billion CNY. The company has shown a year-to-date stock price increase of 22.80% but has faced recent declines in the short term [1]. Financial Performance - For the period from January to September 2025, Te Yi Pharmaceutical achieved a revenue of 692 million CNY, representing a year-on-year growth of 51.86%. The net profit attributable to shareholders was 65.217 million CNY, showing a significant increase of 985.18% compared to the previous year [2]. Shareholder Information - As of September 30, 2025, the number of shareholders for Te Yi Pharmaceutical was 58,100, an increase of 10.11% from the previous period. The average number of tradable shares per shareholder decreased by 9.09% to 6,481 shares [2]. Dividend Distribution - Te Yi Pharmaceutical has distributed a total of 1.059 billion CNY in dividends since its A-share listing, with 356 million CNY distributed over the past three years [3]. Institutional Holdings - Among the top ten circulating shareholders as of September 30, 2025, the third-largest shareholder is the Xingquan Zhongzheng 800 Six-Month Holding Index Enhanced A, holding 3.3338 million shares. The fourth-largest is the Xingquan Hu-Shen 300 Index Enhanced (LOF) A, holding 1.9202 million shares, both of which have not changed in quantity compared to the previous period. The Hong Kong Central Clearing Limited, ranked ninth, reduced its holdings by 7.4217 million shares to 1.3696 million shares [3].

Group 1 - The core viewpoint of the news is that Tianyu Biological has experienced a decline in stock price and financial performance, indicating potential challenges for the company in the market [1][2]. - As of December 23, Tianyu Biological's stock price was 7.67 yuan per share, with a market capitalization of 2.225 billion yuan. The stock has decreased by 4.72% year-to-date and 15.44% over the past 60 days [1]. - The company has seen a net inflow of main funds amounting to 305,600 yuan, with significant buying and selling activity on the stock [1]. Group 2 - Tianyu Biological operates in the agriculture, forestry, animal husbandry, and fishery sector, specifically in pig farming, and is involved in various related concepts such as characteristic towns and PPP concepts [2]. - For the period from January to September 2025, the company reported a revenue of 536 million yuan, a year-on-year decrease of 14.23%, and a net profit attributable to shareholders of -1.61 million yuan, a decrease of 125.22% [2]. - The company has not distributed any dividends in the past three years, with a total payout of 34.54 million yuan since its A-share listing [3].

资料显示，百奥赛图(北京)医药科技股份有限公司位于北京市大兴区中关村科技园区大兴生物医药产业 基地宝参南街12号院，成立日期2009年11月13日，上市日期2025年12月10日，公司主营业务涉及百奥赛 图（北京）医药科技股份有限公司是一家主要提供抗体药物研发和临床前研究服务的中国公司。该公司 运营五个分部。基因编辑服务分部提供基于动物和细胞的定制化基因编辑服务。临床前药理药效评估分 部提供用于药物疗效和毒性评估的临床前药理学服务。模式动物销售分部培育和销售外用和内用模式动 物，亦向客户授出若干模式动物的许可。抗体开发分部识别有潜力成为候选药物的抗体，并就潜在治疗 性抗体分子对外授权或与合作伙伴合作。创新药开发分部研发创新药，专注肿瘤学和自身免疫性疾病治 疗。 责任编辑：小浪快报 12月22日，百奥赛图涨3.14%，成交额3.04亿元。两融数据显示，当日百奥赛图获融资买入额3587.06万 元，融资偿还2158.95万元，融资净买入1428.11万元。截至12月22日，百奥赛图融资融券余额合计1.09 亿元。 融资方面，百奥赛图当日融资买入3587.06万元。当前融资余额1.09亿元，占流通市值的5.88%。 ...

12月22日，摩恩电气涨1.01%，成交额4.25亿元。两融数据显示，当日摩恩电气获融资买入额4382.72万 元，融资偿还3208.25万元，融资净买入1174.46万元。截至12月22日，摩恩电气融资融券余额合计1.84 亿元。 分红方面，摩恩电气A股上市后累计派现1.16亿元。近三年，累计派现878.40万元。 机构持仓方面，截止2025年9月30日，摩恩电气十大流通股东中，金元顺安元启灵活配置混合 （004685）位居第十大流通股东，持股169.82万股，为新进股东。 资料显示，上海摩恩电气股份有限公司位于上海市浦东新区江山路2829号，成立日期1997年10月5日， 上市日期2010年7月20日，公司主营业务涉及电缆业务、电磁线业务以及类金融业务。主营业务收入构 成为：电磁线及其他81.54%，电力电缆12.22%，其他(补充)3.27%，电气装备用电线电缆2.95%，通信电 缆及光缆0.02%。 截至12月10日，摩恩电气股东户数6.27万，较上期减少17.94%；人均流通股7009股，较上期增加 21.86%。2025年1月-9月，摩恩电气实现营业收入12.38亿元，同比增长28.02%；归母净 ...

Group 1 - The core viewpoint of the news highlights the trading performance and financial metrics of Gaoxin Technology Group Co., Ltd., indicating a slight increase in stock price and notable financing activities on December 22 [1] - On December 22, Gaoxin experienced a stock price increase of 2.82%, with a trading volume of 828 million yuan. The net financing buy was -4.15 million yuan, with a total financing balance of 557 million yuan, which is low compared to the past year [1] - The financing balance of Gaoxin accounts for 5.16% of its circulating market value, indicating a relatively low level compared to the 50% percentile over the past year [1] Group 2 - Gaoxin Technology Group, established on November 14, 1997, and listed on July 28, 2010, specializes in the research, production, sales, and service of communication base station and machine room operation management systems [2] - The company's main business revenue composition includes 57.90% from vehicle-mounted terminals, with specific contributions from automotive products (36.05%) and smart justice and video cloud services (27.08%) [2] - For the period from January to September 2025, Gaoxin achieved an operating income of 1.318 billion yuan, representing a year-on-year growth of 39.02%, and a net profit attributable to shareholders of 63.55 million yuan, reflecting a significant increase of 238.18% [2] Group 3 - Since its A-share listing, Gaoxin has distributed a total of 181 million yuan in dividends, with no dividends paid in the last three years [3] - As of September 30, 2025, the number of shareholders in Gaoxin decreased to 89,000, while the average circulating shares per person increased by 8.31% to 17,313 shares [2][3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the third largest, holding 32.55 million shares, an increase of 13.88 million shares from the previous period [3]

Core Viewpoint - The company, Zhongyeda Electric Co., Ltd., has shown mixed financial performance with a slight increase in revenue but a significant rise in net profit year-on-year, indicating potential growth opportunities despite fluctuations in stock trading activity [2][3]. Group 1: Financial Performance - As of September 30, 2025, Zhongyeda achieved operating revenue of 8.343 billion yuan, reflecting a year-on-year growth of 0.61% [2]. - The net profit attributable to shareholders for the same period was 181 million yuan, representing a substantial year-on-year increase of 29.37% [2]. - Cumulatively, the company has distributed 1.669 billion yuan in dividends since its A-share listing, with 626 million yuan distributed over the past three years [3]. Group 2: Stock Trading Activity - On December 22, 2025, Zhongyeda's stock price decreased by 0.33%, with a trading volume of 40.5792 million yuan [1]. - The financing buy-in amount for the day was 4.7578 million yuan, while the financing repayment was 5.2277 million yuan, resulting in a net financing outflow of 469,900 yuan [1]. - The total margin trading balance as of December 22 was 160 million yuan, accounting for 3.23% of the circulating market value, which is above the 60th percentile of the past year [1]. Group 3: Shareholder Structure - As of September 30, 2025, the number of shareholders for Zhongyeda was 27,800, a decrease of 17.03% from the previous period [2]. - The average number of circulating shares per shareholder increased by 20.53% to 14,331 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited ranked as the seventh largest, increasing its holdings by 2.324 million shares to 7.1799 million shares [3].

Core Viewpoint - Ocean King Lighting Technology Co., Ltd. plans to provide a repurchase guarantee of up to 20 million yuan for customers' financing lease business to enhance sales channels and promote business development [1][2]. Group 1: Guarantee Overview - The company aims to collaborate with qualified leasing companies to implement a "financing lease + repurchase guarantee" model, allowing customers to purchase products through leasing while the company receives payment as per the sales contract [2]. - The repurchase guarantee will cover the repayment risks of customers, ensuring that if customers fail to repay on time, the company will assume the repurchase responsibility [2]. Group 2: Conditions for Guaranteed Parties - The guaranteed parties must be non-related customers with good credit, verified by the leasing company, and recommended by the company based on business conditions [3]. - Core conditions for guaranteed parties include good credit for both the customer and their actual controllers, relevant operational qualifications, and a good past cooperation record [3]. Group 3: Board of Directors' Opinion - The board believes that the guarantee is a prudent decision based on market conditions and company circumstances, with risk control measures already in place [4]. - The total approved guarantee amount, including the new 20 million yuan, is 160.8 million yuan, which accounts for 6.10% of the company's latest audited net assets [4]. Group 4: Market Impact - The financing lease model is expected to reduce upfront financial pressure on customers, particularly those needing large equipment purchases, potentially driving order growth in the short term [5]. - The company emphasizes that the repurchase guarantee mechanism, while providing a safety net for customer defaults, will be managed through strict selection criteria to control compensation risks [5].

公告显示，本次回购注销涉及1名已离职激励对象。经第三届董事会第十四次会议审议通过，公司决定 对该名激励对象已获授但尚未解除限售的0.60万股限制性股票进行回购注销。 回购注销具体安排：数量、价格及时间表 登录新浪财经APP 搜索【信披】查看更多考评等级 江西晨光新材料股份有限公司（下称"晨光新材"）近期就2024年限制性股票激励计划披露回购注销事 项。因1名激励对象离职，公司拟对其已获授但尚未解除限售的限制性股票进行回购注销，涉及数量 0.60万股，回购价格6.03元/股，预计总金额约3.62万元，相关手续预计于2025年12月25日完成。 回购注销原因：激励对象离职触发条款 根据晨光新材2024年限制性股票激励计划（下称"《激励计划（草案）》"）相关规定，激励对象若因辞 职、被辞退、裁员或劳动合同到期不再续约等原因离职，其已获授但尚未解除限售的限制性股票不得解 除限售，需由公司按授予价格回购注销。 截至公告披露日，晨光新材已按规定公告了第三届董事会第十四次会议决议、《关于拟回购注销部分限 制性股票的公告》等文件，履行了现阶段信息披露义务。后续，公司将根据回购注销进展情况，继续履 行信息披露义务，并依照《公司 ...

进一步统计，近3个月内该股累计发生37笔大宗交易，合计成交金额为2.53亿元。该股近5个交易日累计 下跌4.96%，主力资金合计净流出4.73亿元。 责任编辑：小浪快报 12月22日，阿特斯收跌1.13%，收盘价为14.94元，发生1笔大宗交易，合计成交量20万股，成交金额269 万元。 第1笔成交价格为13.45元，成交20.00万股，成交金额269.00万元，溢价率为-9.97%，买方营业部为华泰 证券股份有限公司广东分公司，卖方营业部为东吴证券股份有限公司苏州狮山路证券营业部。 ...

后续，公司将按照相关规定办理本次限制性股票的回购注销手续，并及时履行信息披露义务。 声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 据公告，安徽芯瑞达董事会薪酬与考核委员会于2025年12月17日召开2025年第四次会议，审议通过了 《关于回购注销部分限制性股票的议案》。根据核查意见，本次回购注销事项源于公司2023年限制性股 票激励计划预留授予的激励对象中，有1名激励对象因个人原因已离职，不再具备激励对象资格。 根据《上市公司股权激励管理办法》及《公司2023年限制性股票激励计划（草案）》等相关规定，该离 职激励对象已不符合激励条件，公司董事会薪酬与考核委员会同意取消其激励资格，并拟回购注销其已 获授但尚未解除限售的全部限制性股票，共计2399 ...